Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
1.670
-0.010 (-0.60%)
At close: Dec 5, 2025, 4:00 PM EST
1.651
-0.019 (-1.15%)
After-hours: Dec 5, 2025, 6:19 PM EST
Protagenic Therapeutics Employees
The last reported number of employees for Protagenic Therapeutics was 3.
Employees
3
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
3.23M
No historical employees data available.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PTIX News
- 9 days ago - Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice - Accesswire
- 22 days ago - Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study - Accesswire
- 3 months ago - Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance - Accesswire
- 3 months ago - Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders - Accesswire
- 7 months ago - Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity - Accesswire
- 7 months ago - Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher - Benzinga
- 7 months ago - Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders - Accesswire
- 7 months ago - Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split - Accesswire